Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. | ZVRA | $10.36 | $615.22M | 10.9 | — |
| CorMedix Inc. | CRMD | $7.79 | $607.19M | 3.8 | — |
| DBV Technologies S.A. | DBVT | $9.62 | $604.60M | — | |
| Climb Bio, Inc. | CLYM | $10.87 | $592.17M | — | |
| ProKidney Corp. | PROK | $1.44 | $574.82M | — | |
| Phathom Pharmaceuticals, Inc. | PHAT | $7.03 | $568.73M | — | |
| Electra Therapeutics, Inc. Common stock | ETRA | $9.05 | $568.04M | — | |
| Puma Biotechnology, Inc. | PBYI | $10.90 | $562.66M | 21.4 | — |
| Aclaris Therapeutics, Inc. | ACRS | $3.81 | $560.83M | — | |
| Shattuck Labs, Inc. | STTK | $5.58 | $560.03M | — | |
| MiMedx Group, Inc. | MDXG | $3.74 | $545.79M | 93.5 | — |
| Faeth Therapeutics, Inc. | FTH | $20.57 | $531.54M | — | |
| Entera Bio Ltd. | ENTX | $3.05 | $530.19M | — | |
| Valneva SE | VALN | $5.56 | $527.22M | — | |
| CytomX Therapeutics, Inc. | CTMX | $2.40 | $522.96M | — | |
| Neurogene Inc. | NGNE | $26.08 | $521.90M | — | |
| Fennec Pharmaceuticals Inc. | FRX.TO | CA$14.76 Oct 20, 2026 | CA$517.59M | — | |
| Eupraxia Pharmaceuticals Inc. | EPRX | $7.73 | $510.75M | — | |
| Bright Minds Biosciences Inc. | DRUG | $50.44 | $497.54M | — | |
| Arvinas, Inc. | ARVN | $7.56 | $487.46M | 29.1 | — |
| Monopar Therapeutics Inc. | MNPR | $72.35 | $485.63M | — | |
| Oculis Holding AG | OCS | $7.87 | $484.70M | — | |
| Ovid Therapeutics Inc. | OVID | $2.47 | $482.39M | — | |
| BlossomHill Therapeutics, Inc. | BLSM | $15.60 | $476.14M | — | |
| REGENXBIO Inc. | RGNX | $7.17 | $473.31M | — | |
| DiaMedica Therapeutics Inc. | DMAC | $8.69 | $468.61M | — | |
| Crescent Biopharma, Inc. | CBIO | $13.17 | $467.31M | — | |
| Allogene Therapeutics, Inc. | ALLO | $1.33 | $459.50M | — | |
| MapLight Therapeutics, Inc. | MPLT | $8.16 | $453.50M | — | |
| AgomAb Therapeutics NV | AGMB | $9.11 | $448.65M | — | |
| Altimmune, Inc. | ALT | $2.23 | $433.77M | — | |
| Eikon Therapeutics, Inc. | EIKN | $8.00 | $433.32M | — | |
| Autolus Therapeutics plc | AUTL | $1.62 | $431.18M | — | |
| Tectonic Therapeutic, Inc. | TECX | $21.84 | $426.96M | — | |
| Indaptus Therapeutics, Inc. | INDP | $3.16 | $421.05M | — | |
| TRex Bio, Inc. | TRXB | $15.24 | $418.27M | — | |
| Assembly Biosciences, Inc. | ASMB | $20.46 | $416.58M | — | — |
| ARS Pharmaceuticals, Inc. | SPRY | $4.18 | $415.69M | — | |
| Prothena Corporation plc | PRTA | $8.03 | $412.24M | — | |
| YD Bio Ltd | YDES | $5.77 | $408.70M | — | |
| Capricor Therapeutics, Inc. | CAPR | $5.88 | $400.00M | — | |
| Zura Bio Limited | ZURA | $4.13 | $395.77M | — | |
| Editas Medicine, Inc. | EDIT | $2.51 | $385.49M | — | |
| Scribe Therapeutics Inc. | SCTX | $19.30 | $365.38M | — | |
| Fennec Pharmaceuticals Inc. Common Stock | FENC | $10.38 | $364.00M | — | |
| Kyverna Therapeutics, Inc. | KYTX | $5.84 | $361.17M | — | |
| Rezolute, Inc. | RZLT | $3.70 | $357.87M | — | |
| Orchestra BioMed Holdings, Inc. | OBIO | $5.81 | $348.91M | — | |
| Nautilus Biotechnology, Inc. | NAUT | $2.71 | $344.86M | — | |
| Relmada Therapeutics, Inc. | RLMD | $3.21 | $342.41M | — |
Zevra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $615.22M
- P/E
- 10.9
CorMedix Inc.
Healthcare / Biotechnology
- Market Cap
- $607.19M
- P/E
- 3.8
DBV Technologies S.A.
Healthcare / Biotechnology
- Market Cap
- $604.60M
- P/E
- unprofitable
Climb Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $592.17M
- P/E
- unprofitable
ProKidney Corp.
Healthcare / Biotechnology
- Market Cap
- $574.82M
- P/E
- unprofitable
Phathom Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $568.73M
- P/E
- unprofitable
Electra Therapeutics, Inc. Common stock
Healthcare / Biotechnology
- Market Cap
- $568.04M
- P/E
- unprofitable
Puma Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $562.66M
- P/E
- 21.4
Aclaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $560.83M
- P/E
- unprofitable
Shattuck Labs, Inc.
Healthcare / Biotechnology
- Market Cap
- $560.03M
- P/E
- unprofitable
MiMedx Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $545.79M
- P/E
- 93.5
Faeth Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $531.54M
- P/E
- unprofitable
Entera Bio Ltd.
Healthcare / Biotechnology
- Market Cap
- $530.19M
- P/E
- unprofitable
Valneva SE
Healthcare / Biotechnology
- Market Cap
- $527.22M
- P/E
- unprofitable
CytomX Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $522.96M
- P/E
- unprofitable
Neurogene Inc.
Healthcare / Biotechnology
- Market Cap
- $521.90M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- CA$517.59M
- P/E
- unprofitable
Eupraxia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $510.75M
- P/E
- unprofitable
Bright Minds Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $497.54M
- P/E
- unprofitable
Arvinas, Inc.
Healthcare / Biotechnology
- Market Cap
- $487.46M
- P/E
- 29.1
Monopar Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $485.63M
- P/E
- unprofitable
Oculis Holding AG
Healthcare / Biotechnology
- Market Cap
- $484.70M
- P/E
- unprofitable
Ovid Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $482.39M
- P/E
- unprofitable
BlossomHill Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $476.14M
- P/E
- unprofitable
REGENXBIO Inc.
Healthcare / Biotechnology
- Market Cap
- $473.31M
- P/E
- unprofitable
DiaMedica Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $468.61M
- P/E
- unprofitable
Crescent Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $467.31M
- P/E
- unprofitable
Allogene Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $459.50M
- P/E
- unprofitable
MapLight Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $453.50M
- P/E
- unprofitable
AgomAb Therapeutics NV
Healthcare / Biotechnology
- Market Cap
- $448.65M
- P/E
- unprofitable
Altimmune, Inc.
Healthcare / Biotechnology
- Market Cap
- $433.77M
- P/E
- unprofitable
Eikon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $433.32M
- P/E
- unprofitable
Autolus Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $431.18M
- P/E
- unprofitable
Tectonic Therapeutic, Inc.
Healthcare / Biotechnology
- Market Cap
- $426.96M
- P/E
- unprofitable
Indaptus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $421.05M
- P/E
- unprofitable
TRex Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $418.27M
- P/E
- unprofitable
Assembly Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $416.58M
ARS Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $415.69M
- P/E
- unprofitable
Prothena Corporation plc
Healthcare / Biotechnology
- Market Cap
- $412.24M
- P/E
- unprofitable
YD Bio Ltd
Healthcare / Biotechnology
- Market Cap
- $408.70M
- P/E
- unprofitable
Capricor Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $400.00M
- P/E
- unprofitable
Zura Bio Limited
Healthcare / Biotechnology
- Market Cap
- $395.77M
- P/E
- unprofitable
Editas Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $385.49M
- P/E
- unprofitable
Scribe Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $365.38M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $364.00M
- P/E
- unprofitable
Kyverna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $361.17M
- P/E
- unprofitable
Rezolute, Inc.
Healthcare / Biotechnology
- Market Cap
- $357.87M
- P/E
- unprofitable
Orchestra BioMed Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $348.91M
- P/E
- unprofitable
Nautilus Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $344.86M
- P/E
- unprofitable
Relmada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $342.41M
- P/E
- unprofitable
Showing 201–250 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.